200 millions of cases and more than 500000 death are worth every effort to deal with the world wide pest named malaria. A report in nature from a multicentric group with the Welcome Trust and Glaxo has found a new drug with the so-far non-attractive name DDD107498, which has excellent non-clinical parameters. It is drug specifically active against the translation elongation factor 2 (eEF2) of Plasmodium falciparum . 

A patent for the drug is filed (PCT/GB2009/002084).